Effect of achieving bone sterilisation on bone architecture and bone marrow, in an experimental rabbit model of osteomyelitis caused by carbapenemase-producing Enterobacterales.
Animals
Rabbits
Klebsiella Infections
/ drug therapy
Bone Marrow
Ceftazidime
/ pharmacology
Anti-Bacterial Agents
/ pharmacology
Bacterial Proteins
beta-Lactamases
/ pharmacology
Osteomyelitis
/ drug therapy
Escherichia coli
Azabicyclo Compounds
/ pharmacology
Klebsiella pneumoniae
Microbial Sensitivity Tests
Bone architecture
Bone marrow
KPC
Modification
OXA-48
Osteomyelitis
Journal
International journal of antimicrobial agents
ISSN: 1872-7913
Titre abrégé: Int J Antimicrob Agents
Pays: Netherlands
ID NLM: 9111860
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
14
06
2023
revised:
05
09
2023
accepted:
29
09
2023
medline:
4
12
2023
pubmed:
16
10
2023
entrez:
15
10
2023
Statut:
ppublish
Résumé
Natural history and treatment of bone infections caused by carbapenemase-producing Enterobacterales (CPE) are poorly defined. We evaluated the effect of treatment on the progression of subacute osteomyelitis in a rabbit model. Two isolates were used: a KPC-producing Klebsiella pneumoniae and an Escherichia coli harbouring bla Bone marrow modifications induced by local infection were similar between prematurely deceased animals and non-sterilised animals (P = 0.14) but differed significantly from animals that achieved bone sterilisation after treatment (P = 0.04). Conversely, when comparing bone deformity, rabbits who died early (n = 13) had similar bone architecture as those achieving bone sterilisation (P = 0.12), as opposed to those not sterilised after treatment (P = 0.04). After a multivariate logistic regression, bone marrow scale ≤2 was associated with bone sterilisation (P < 0.001), and bone architecture scale ≤2 was associated with bone sterilisation (adjusted odds ratio = 2.7; 95% confidence interval 1.14-6.37) and KPC infection (adjusted odds ratio = 5.1; 95% confidence interval 2.17-12.13). Effective antibacterial treatment reduces bone architecture distortion and bone marrow changes. These variables may be used as proxy for bone sterilisation.
Identifiants
pubmed: 37839717
pii: S0924-8579(23)00277-7
doi: 10.1016/j.ijantimicag.2023.107003
pii:
doi:
Substances chimiques
carbapenemase
EC 3.5.2.6
Ceftazidime
9M416Z9QNR
Anti-Bacterial Agents
0
Bacterial Proteins
0
beta-Lactamases
EC 3.5.2.6
Azabicyclo Compounds
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
107003Informations de copyright
Copyright © 2023 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.